Stock A128940 HANMI PHARM. CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Hanmi Pharm. Co., Ltd.

Equities

A128940

KR7128940004

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 29/04/2024 BST 		5-day change 1st Jan Change
316,500 KRW -0.63% Intraday chart for Hanmi Pharm. Co., Ltd. +0.96% -10.21%
05-01 Hanmi Pharm Q1 Profit Surges 27.5%, Sales Up 11.8% MT
03-19 Hanmi Pharm. Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Chart calendar Hanmi Pharm. Co., Ltd.

812d9.RKjPiiZSZkcv0cWfiFbfX41QIPG5dugKWZSvQwePxyU.LOKN2ldjJwVdhIbl8QyAaus2baHTFbdZb__eFF_him0r-5XGRGUCdWOHog~b9fbeaa149e295ce0d3d42f05ac871ac

Upcoming events on Hanmi Pharm. Co., Ltd.

13/08/2024 Q2 2024 Earnings Release (Projected)
12/11/2024 Q3 2024 Earnings Release (Projected)
05/02/2025 Q4 2024 Earnings Release (Projected)

Past events on Hanmi Pharm. Co., Ltd.

30/04/2024 08:30 Q1 2024 Earnings Call
29/04/2024 Q1 2024 Earnings Release
03/04/2024 05:30 Mirae Asset Global Healthcare Prescription Corporate Day
08/03/2024 04:00 Citi Korea Investor Conference
08/02/2024 01:00 SAMSUNG Healthcare Virtual Corporate Day
07/02/2024 00:10 Non Deal Roadshow
02/02/2024 07:00 Q4 2023 Earnings Call
01/02/2024 Q4 2023 Earnings Release
08/11/2023 00:10 Non Deal Roadshow
03/11/2023 00:20 Non-Deal Roadshow
01/11/2023 07:00 Q3 2023 Earnings Call
31/10/2023 Q3 2023 Earnings Release
21/09/2023 01:30 Kiwoom Securities Corporate Day
11/09/2023 KB Korea Conference
22/08/2023 02:00 KIS Global Investors Conference
27/07/2023 Q2 2023 Earnings Release
13/06/2023 01:30 NH Investment & Securities The C FORUM
11/05/2023 01:20 Roadshow
04/05/2023 01:10 Roadshow - Meritz Securities
02/05/2023 01:10 Roadshow - NH Investment & Securities

Past dividends on Hanmi Pharm. Co., Ltd.

26/12/2023 Annual 500 KRW
27/12/2022 Annual 500 KRW
28/12/2021 Annual 500 KRW
28/12/2020 Annual 500 KRW
26/12/2019 Annual 500 KRW
26/12/2018 Annual 500 KRW
26/12/2017 Annual 500 KRW
28/12/2015 Annual 2000 KRW

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Billions KRW		Released
Forecast
Spread 		1 114
1 111
0.19%		1 076
1 108
-2.86%		1 206
1 157
4.21%		1 332
1 342
-0.8%		1 491
1 468
1.54%
1 627

EBITDA
Billions KRW		Released
Forecast
Spread 		159
151
5.24%		110
106
4.53%		215
190
12.68%		255
244
4.68%		319
307
3.89%
335

EBIT
Billions KRW		Released
Forecast
Spread 		104
93,5
11.18%		48,7
47,8
1.81%		127
112
13.45%		157
156
0.62%		221
212
4.13%
238

Earnings before Tax (EBT)
Billions KRW		Released
Forecast
Spread 		83,3
76,2
9.29%		22,1
12,9
71.68%		104
99,0
4.84%		117
138
-15.11%		194
192
1.21%
221

Net income
Billions KRW		Released
Forecast
Spread 		52,1
45,4
14.78%		12,0
3,08
288.46%		81,1
68,3
18.69%		76,9
93,1
-17.42%		159
140
14.1%
159

EPS
KRW		Released
Forecast
Spread 		4 170
3 543
17.7%		939
236
298.29%		5 270
5 356
-1.6%		7 994
6 958
14.89%		11 522
11 182
3.04%
12 411

Announcement Date07/02/2004/02/2127/01/2208/02/2302/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Billions KRW		Released
Forecast
Spread 		350
319
9.86%		321
307
4.52%		317
308
2.87%		342
327
4.58%		351
367
-4.16%		362
360
0.38%		343
347
-1.35%		365
369
-1.29%		422
402
5%
398


383


400


444


414

EBITDA
Billions KRW		Released
Forecast
Spread





54,5
42,6
27.87%		72,7
56,9
27.84%		64,1
59,0
8.65%		84,6
76,0
11.28%		57,8
70,0
-17.38%
78,0

94,7
65,3
45.05%
94,8


74,1


85,6


74,3




EBIT
Billions KRW		Released
Forecast
Spread 		42,7
35,2
21.49%		38,7
34,1
13.37%		29,6
23,0
28.77%		46,8
39,5
18.61%		37,8
40,3
-6.32%		60,5
50,6
19.55%		33,2
37,5
-11.6%		57,5
51,9
10.89%		70,1
64,9
7.95%
66,0


47,3


58,5


67,1


76,0

Earnings before Tax (EBT)
Billions KRW		Released
Forecast
Spread 		34,1
27,6
23.52%		35,7
27,4
30.19%		26,4
22,5
17.36%		37,9
35,3
7.22%		16,6
36,7
-54.75%		55,6
49,1
13.4%		25,4
30,4
-16.43%		56,3
47,7
18.09%		56,9
58,4
-2.61%
68,6


41,9


60,7


56,7


83,0

Net income
Billions KRW		Released
Forecast
Spread 		17,5
17,3
1.17%		19,3
21,0
-8.06%		18,0
14,8
21.47%		25,4
24,4
4.21%		13,6
25,8
-47.16%		43,1
30,6
40.88%		16,1
21,0
-23.54%		54,7
32,7
67.31%		47,4
39,8
19.32%
48,8


29,5


45,3


30,8




Announcement Date27/01/2227/04/2218/07/2201/11/2208/02/2326/04/2328/07/2301/11/2302/02/24-----

Upcoming sector events for Hanmi Pharm. Co., Ltd.

06/05/2024 SANDOZ GROUP AG: Q1 2024 Sales and Revenue Release
07/05/2024 SANOFI INDIA LIMITED: Q1 2024 Earnings Release (Projected)
08/05/2024 ZERIA PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
08/05/2024 ONO PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
09/05/2024 CIPLA LIMITED: Q4 2024 Earnings Release
09/05/2024 CELLTRION PHARM, INC.: Q1 2024 Earnings Release (Projected)
12/05/2024 DAEWOONG CO., LTD.: Q1 2024 Earnings Release (Projected)
12/05/2024 SAM CHUN DANG PHARM. CO., LTD: Q1 2024 Earnings Release (Projected)
12/05/2024 CAREGEN CO., LTD.: Q1 2024 Earnings Release (Projected)
12/05/2024 CHONG KUN DANG PHARMACEUTICAL CORP.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Hanmi Pharm. Co., Ltd.

Today AJANTA PHARMA LIMITED: Q4 2024 Earnings Release (Projected)
Today PROCTER & GAMBLE HEALTH LIMITED: Q3 2024 Earnings Release (Projected)
29/04/2024 SINOTHERAPEUTICS INC.: Q4 2023 Earnings Release
29/04/2024 KUNMING LONGJIN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
29/04/2024 OTSUKA HOLDINGS CO., LTD.: Q1 2024 Earnings Release
29/04/2024 YIFAN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
29/04/2024 HANMI PHARM. CO., LTD.: Q1 2024 Earnings Release
28/04/2024 SINOTHERAPEUTICS INC.: Q1 2024 Earnings Release
28/04/2024 SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.: Q1 2024 Earnings Release
27/04/2024 CHONGQING PHARSCIN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A128940 Stock
  4. Calendar Hanmi Pharm. Co., Ltd.